These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22353618)

  • 1. Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.
    Devriendt B; De Geest BG; Goddeeris BM; Cox E
    J Control Release; 2012 Jun; 160(3):431-9. PubMed ID: 22353618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing oral vaccines targeting intestinal dendritic cells.
    Devriendt B; De Geest BG; Cox E
    Expert Opin Drug Deliv; 2011 Apr; 8(4):467-83. PubMed ID: 21375470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectins and microparticles for enhanced oral vaccination.
    Lavelle EC
    Methods; 2006 Feb; 38(2):84-9. PubMed ID: 16406570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination.
    Kim SH; Seo KW; Kim J; Lee KY; Jang YS
    J Immunol; 2010 Nov; 185(10):5787-95. PubMed ID: 20952686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle uptake and translocation across epithelial membranes.
    Thomas NW; Jenkins PG; Howard KA; Smith MW; Lavelle EC; Holland J; Davis SS
    J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):487-90. PubMed ID: 8982821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioadhesive delivery systems for mucosal vaccine delivery.
    Baudner BC; O'Hagan DT
    J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting receptor biology for oral vaccination with biodegradable particulates.
    Foster N; Hirst BH
    Adv Drug Deliv Rev; 2005 Jan; 57(3):431-50. PubMed ID: 15560950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery.
    Brayden DJ; Baird AW
    Adv Drug Deliv Rev; 2004 Apr; 56(6):721-6. PubMed ID: 15063586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic plant-based oral vaccines.
    Lugade AA; Kalathil S; Heald JL; Thanavala Y
    Immunol Invest; 2010; 39(4-5):468-82. PubMed ID: 20450287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral vaccination and vaccine-entrapped microparticle delivery system].
    Li FQ; Fei YB; Su H; Hu JH
    Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
    Wells J
    Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-associated lymphoid tissues for the development of oral vaccines.
    Kunisawa J; Kurashima Y; Kiyono H
    Adv Drug Deliv Rev; 2012 May; 64(6):523-30. PubMed ID: 21827802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells?
    Kaiserlian D; Etchart N
    Semin Immunol; 1999 Jun; 11(3):217-24. PubMed ID: 10381867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.